Quantcast

Global Medical Imaging Reagents Market 2012-2016

April 15, 2014

DUBLIN, Apr. 15, 2014 /PRNewswire/ –

Research and Markets

(

http://www.researchandmarkets.com/research/f9jczp/global_medical

) has announced the addition of the

“Global Medical Imaging Reagents Market Report”

report to their offering.




(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The analysts forecast the Global Medical Imaging Reagents market to grow at a CAGR of 7.95 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Medical Imaging Reagents market has also been witnessing the increasing demand for radiopharmaceuticals. However, the lack of reimbursements for imaging procedures could pose a challenge to the growth of this market.




The report, Global Medical Imaging Reagents Market Report, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Medical Imaging Reagents market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.




As a result of the rise in the incidences of cardiovascular, oncological, and neurological disorders among the population, there has been an increase in the volume of PET, SPECT, SPECT-CT, PET-MRI, and SPECT-MRI procedures for imaging and diagnosis over recent years.


Imaging without utilization of radiopharmaceuticals has also become indispensable owing to their ability to diagnose various disease processes much earlier than other diagnostic tests. For instance, it is expected that an increasing number of oncology and cardiology procedures will drive the demand for radiopharmaceuticals such as fluorodeoxyglucose used for PET scans. Thus, the increasing demand for radiopharmaceuticals is expected to fuel the growth in this market.



According to the report, one of the main drivers in this market is the increasing global aging population and associated increase in incidences of cardiovascular diseases, neurological disorders, gastrointestinal diseases, and oncologic disorders among the aged population. The rise in demand for diagnostic screening of elderly patients has enhanced the need of imaging reagents.



Further, the report states that one of the major challenges in the market is the lack of reimbursements policies for imaging procedures, which reduces people’s desire to opt for imaging procedures that are expensive.



The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.



Key Topics Covered:



1. Executive Summary

2. Scope of the Report

3. Market Research Methodology

4. List of Abbreviations

5. Introduction

6. Market Landscape

7. Market Segmentation by Product

8. Geographical Segmentation

9. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

17. Key Vendor Analysis

18. Other Reports in this Series





Companies Mentioned:

    --  Aspect Imaging
    --  Bayer AG
    --  Bracco S.p.A
    --  Covidien plc
    --  GE Healthcare
    --  Guerbet SA
    --  IBA Molecular Imaging
    --  Lantheus Medical Imaging Inc.
    --  PerkinElmer Inc.



For more information visit http://www.researchandmarkets.com/research/f9jczp/global_medical



Media Contact:

Laura Wood , +353-1-481-1716, press@researchandmarkets.net




SOURCE Research and Markets


Source: PR Newswire



comments powered by Disqus